Calcimedica, Inc.
Clinical trials sponsored by Calcimedica, Inc., explained in plain language.
-
New drug shows promise in severe COVID-19 pneumonia trial
Disease control CompletedThis study tested a drug called Auxora in 314 people with severe COVID-19 pneumonia. The goal was to see if it could help them recover faster and reduce deaths. Participants received either Auxora or a placebo through an IV over 48 hours. The trial was completed and results are b…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New drug shows promise for severe pancreatitis in early trial
Disease control CompletedThis study tested a new medicine called CM4620-IE in 21 people with severe pancreatitis and body-wide inflammation (SIRS). The goal was to see if the drug is safe and helps control the disease. Participants received either the drug plus standard care or standard care alone. The s…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug may help pancreatitis patients eat solid food faster
Symptom relief CompletedThis study tested a drug called Auxora in 216 people hospitalized with acute pancreatitis (a sudden, painful pancreas inflammation) and a related body-wide inflammatory response (SIRS). Participants received either one of three doses of Auxora or a placebo as an IV infusion daily…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Symptom relief
Last updated May 26, 2026 09:42 UTC